U.S. flag

An official website of the United States government

NM_015047.3(EMC1):c.2059C>T (p.Arg687Ter) AND not provided

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Sep 18, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000760591.9

Allele description [Variation Report for NM_015047.3(EMC1):c.2059C>T (p.Arg687Ter)]

NM_015047.3(EMC1):c.2059C>T (p.Arg687Ter)

Genes:
EMC1-AS1:EMC1 antisense RNA 1 [Gene - HGNC]
EMC1:ER membrane protein complex subunit 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p36.13
Genomic location:
Preferred name:
NM_015047.3(EMC1):c.2059C>T (p.Arg687Ter)
HGVS:
  • NC_000001.11:g.19230849G>A
  • NG_032948.1:g.25711C>T
  • NM_001271427.2:c.2056C>T
  • NM_001271428.2:c.2056C>T
  • NM_001271429.2:c.1993C>T
  • NM_015047.3:c.2059C>TMANE SELECT
  • NP_001258356.1:p.Arg686Ter
  • NP_001258357.1:p.Arg686Ter
  • NP_001258358.1:p.Arg665Ter
  • NP_055862.1:p.Arg687Ter
  • NC_000001.10:g.19557343G>A
  • NM_015047.2:c.2059C>T
Protein change:
R665*
Links:
dbSNP: rs901905420
NCBI 1000 Genomes Browser:
rs901905420
Molecular consequence:
  • NM_001271427.2:c.2056C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001271428.2:c.2056C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001271429.2:c.1993C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_015047.3:c.2059C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000890482GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Pathogenic
(Sep 18, 2024)
germlineclinical testing

Citation Link,

SCV001198808Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jan 5, 2022)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Forcible destruction of severely misfolded mammalian glycoproteins by the non-glycoprotein ERAD pathway.

Ninagawa S, Okada T, Sumitomo Y, Horimoto S, Sugimoto T, Ishikawa T, Takeda S, Yamamoto T, Suzuki T, Kamiya Y, Kato K, Mori K.

J Cell Biol. 2015 Nov 23;211(4):775-84. doi: 10.1083/jcb.201504109. Epub 2015 Nov 16.

PubMed [citation]
PMID:
26572623
PMCID:
PMC4657166

Monoallelic and Biallelic Variants in EMC1 Identified in Individuals with Global Developmental Delay, Hypotonia, Scoliosis, and Cerebellar Atrophy.

Harel T, Yesil G, Bayram Y, Coban-Akdemir Z, Charng WL, Karaca E, Al Asmari A, Eldomery MK, Hunter JV, Jhangiani SN, Rosenfeld JA, Pehlivan D, El-Hattab AW, Saleh MA, LeDuc CA, Muzny D, Boerwinkle E; Baylor-Hopkins Center for Mendelian Genomics, Gibbs RA, Chung WK, Yang Y, Belmont JW, et al.

Am J Hum Genet. 2016 Mar 3;98(3):562-570. doi: 10.1016/j.ajhg.2016.01.011.

PubMed [citation]
PMID:
26942288
PMCID:
PMC4800043
See all PubMed Citations (4)

Details of each submission

From GeneDx, SCV000890482.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001198808.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 620228). This variant has not been reported in the literature in individuals affected with EMC1-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change creates a premature translational stop signal (p.Arg687*) in the EMC1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EMC1 are known to be pathogenic (PMID: 26572623, 26942288, 29271071).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024